Stock trades 141% above intrinsic value while insiders buy $102M worth at negative real yields.

A once-stable earnings machine now trades at premium multiples while destroying capital value, yet management loads up on shares.

Does the price protect me from permanent loss of capital?

This framework sees no margin of safety whatsoever. The price demands heroic assumptions about future growth and capital efficiency recovery that the current fundamentals do not support.

Has the company proven it can generate consistent earnings over many years?

The earnings record is exemplary - near-perfect execution over a decade. Yet Mr. Market yawns at beats and celebrates the rare miss, suggesting fatigue with mere consistency.

Can this company survive a prolonged downturn?

The fortress has taken on debt to fund expansion just as capital efficiency deteriorates. Interest coverage remains adequate but the leverage buildup during a cyclical peak raises concerns.

Is the manic-depressive business partner creating opportunity or danger?

Mr. Market has grown weary of consistent execution and prices the business for perfection. The relief rally on the lone miss reveals dangerous positioning where good news disappoints.

Applying this framework reveals a paradox: impeccable earnings execution coupled with deteriorating capital efficiency, all wrapped in a price that offers no protection. The 141% premium to DCF value while yielding less than treasuries violates every principle of margin of safety. Yet insiders bet $102 million that Mr. Market is wrong - do they see a catalyst the numbers miss?

This analysis applies Benjamin Graham's published investment framework to publicly available financial data. It is not authored by, endorsed by, or affiliated with Benjamin Graham. Educational purposes only. Not financial advice.